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SUMMARY
Death rates from colorectal cancerin Northern Ireland are higher than in most of
the rest of the United Kingdom. Although local surgeons have recognised this
problem for some time it has remained unclear whether this reflects a greater
underlying incidence or a worse mortality. We have reviewed all histological
diagnoses of colorectal cancer in the province over a three year period and we
report the incidence and site distribution for this disease in thispopulation ofone
and a halfmillion.
With the exception ofrectal cancer in females the incidence ofcolorectal cancer,
whether histologically diagnosed orregistered, is higher than in England, Wales
or Scotland The site distribution accords with that in other high risk countries.
These results indicate thatNorthern Ireland has the highest underlying incidence
ofcolorectal cancer in the United Kingdom.
INTRODUCTION
It is known that Northern Ireland has one of the highest death rates from
colorectal cancer in the United Kingdom;I reliable province-wide incidence data
has not previously been reported. There has been a local cancer registry since
1959, but its data-base has not been routinely collated by the International
Association of Cancer Registries for inclusion in the World Health Organisation's
"Cancer Incidence in Five Continents".2
Mortality trends for these two cancers in Northern Ireland have not followed the
pattern of post-war decline in the rest of the United Kingdom.3 Internationally,
mortality and incidence for this disease show a high correlation4 but there are
known to be significant variations in incidence between relatively small areas
within the UK.5As partofa largerstudy intotheepidemiology ofhereditary bowel
cancer, we report the age and sex specific incidence, and site distribution, of all
histologically confirmed bowel tumours diagnosed over a three year period in the
1 -5 million population of Northem Ireland.
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METHODS
All new histological diagnoses of cancer of the colon and rectum were reviewed
from thetopographically indexed records ofthethree histopathology laboratories
in the province between 1976 and 1978. From the operative request and the
pathology report, details of the age and sex of the patient and the site of the
primary tumour were obtained. Metachronous or recurrent cancers during the
period were not included and only the site of the first growth (or the largest if
synchronous tumours were present) was recorded. The cancers were assigned to
five anatomical sites: caecum and ascending colon; transverse colon (including
hepatic and splenic flexures); descending colon; sigmoid colon; rectum and anal
canal. In accordance with the Intemational Classification of Diseases, "recto-
sigmoid" junction growths were routinely assigned to the rectal group. Mid-year
population estimates (in five year age groups) for 1976-78 were obtained from
the Northem Ireland Registrar General's Office, and age-standardised incidence
rates were computed using a truncated world standard population.2
For comparison purposes, an age and sex breakdown of colorectal cancer
registrations of new cases notified between 1976 and 1978 was requested from
the local cancer register. Incidence was therefore calculated both for histo-
logically confirmed cases and for registered cases. Comparisons were made with
registration data from England, Wales and Scotland.
Analysis of variance was used to compare the mean age at diagnosis of cases
at different bowel sites. A z statistic and a chi-square statistic were calculated
to compare incidence rates and site distribution respectively between men
and women.
RESULTS
There were 1241 histologically diagnosed cases and 1847 new cases registered
over the period 1976-78. For two ofthe laboratory cases no age was given and
they have been excluded from further analysis. The average age of patients with
histologically confirmed colon and rectal cancer was 65*3 yrs (range 23-99)
and 66 2 yrs (range 20-99) respectively. Although at relatively young ages
the incidence of colon cancer in women appeared to exceed that in men, the
difference in the 25-44 yrs age group was not significant. With the exception of
the youngest age groups (for whom rates are based on small numbers of cases)
the incidence of rectal cancer in men appeared higher than that in women. The
difference between the sexes was not significant. (Fig 1).
Women have a greater proportion ofproximal disease (ascending andtransverse)
than men (28'4% versus 19 1 %). The differences intheproportionsofproximal
and distal disease were significant (chi-square = 13-56, df= 1, p < 0 001). The
average age of females with proximal colon cancers (ascending and transverse)
was some five years greater than those with distal disease and so the site
distribution has been represented for each sex separately in two broad age
categories (Fig 2). Theproportion ofproximal disease seems to increase with age
for females but not for males. For males the distribution is dominated by the
proportion of rectal cancer.
The age-standardised incidence (in age groups 35-64 yrs) of histologically
confirmed cancer and of registered cancer is shown in the Table, with data from
cancer registrations for England, Wales and Scotland shown for comparison.
©3 The Ulster Medical Society, 1990.
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Fig 1. Age specific incidence of histologically confirmed colorectal cancer (per 100,000)
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Fig 2. Site distribution of histologically confirmed bowel tumours in males and females
(proportions calculated separately for each sex)
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The incidence in Northern Ireland of laboratory confirmed colon cancer in
females and of rectal cancer in males is higher that equivalent registered rates
in the rest ofthe UK. With the exception ofrectal cancer in females, the incidence
of registered colorectal cancer in Northern Ireland is the highest in the UK.
TABLE
Age standardised incidence (per 100,000) ofcolorectal cancer
in the United Kingdom (35-64 yrs)
Colon Rectum
M F M F
Northern Ireland 17-5 22-2 1941 10 2
(histological)
Northern Ireland 26-1 26-6 16-6 9 8
(registered)
Scotland* 22-2 21 3 14-8 10-8
(period 1978-82)
England&,Wales* 17 6 17 1 15-2 9-6
(period 1979-82)
'Source: Cancer Incidence in Five Continents, Vol V.
World Health Organisation 1987. Data based on pooled rates from contributing registries.
DISCUSSION
These observations have provided incidence data on histologically confirmed
colorectal cancer in Northern Ireland, and also the opportunity to contrast these
findings with the data recorded in the Northern Ireland Cancer Register. The
concern that colorectal cancerisaparticularly serious problemin Northern Ireland
has been substantiated, and our findings come at an opportune time in view
of the current interest in strategies for colorectal cancer prevention.6 There is
growing evidence that proximal and distal cancers may represent biologically
distinct diseases,7 and there has been renewed attention on regional variations in
site distribution within the bowel.
It is not possible reliably to assess the site distribution of colorectal cancer from
the Northern Ireland Cancer Register because over half of all colon registrations
have site unspecified. However the findings of the histological case review and
the pattern of age-specific incidence are consistent with the concept that the
dominant aetiological influences may differ in the two sexes.58 Women in
Northern Ireland have higher rates of colon cancer at younger ages than men.
Although the difference in rates is not significant the same pattern has been
confirmed in many western developed countries in North America, Europe and
Australia.8 Local women have a greater proportion ofproximal disease than men.
This general distribution pattern is congruent with those described for medium
and high risk countries such as in Great Britain, Scandinavia and New Zealand
which has reputedly the highest mortality in the world.9 Gender differences in
the age-specific incidence rates have been attributed to physiological changes
associated with the reproductive years which may modify risk status by altering
bile acid secretion.8
© The Ulster Medical Society, 1990.
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It is harder to explain the proximal shift with age of colon cancer in females but
not males. This is not to be confused with the apparently increasing proportion
of proximal disease diagnosed in a number of countries in recent decades in
Scandinavia and North America.1011 Some have noted that this recently growing
proportion of proximal disease appears to be more marked in the over 65 year
age group14 tending to support an aging gut hypothesis. However retrospective
cohort and cross-sectional survey designs tend to be more prone to a number of
biases. It is likely that proximal tumours have a longer sojourn time and become
symptomatic at a later stage in their biological course.12 Younger patients are
therefore likely to have relatively fewer right sided lesions than their older fellows.
Less than five percent of tumours in this histological series could not be sited due
to lack of information on the operative request or pathology report. Their age
distribution was no different to the anatomically sited cases. However a detection
bias might still be contributing to the profile of laboratory cases as there were far
more cases registered (over 65 yrs) than histologically diagnosed (1 *75 cases
registered per case histologically diagnosed). The shortfall in numbers (for those
over 65 yrs) was least for males with rectal cancer (1.11 cases registered per
case histologically diagnosed). Presumably rectal cancer requires less invasive
investigation and is therefore more immediately detectable than more proximal
disease.
The key finding in our study was the very high incidence of histologically
confirmed colorectal cancer in Northern Ireland. How much credence can be
placed onour estimatesof incidence? Firstly, we have reported both histologically
confirmed and registered cases of colorectal cancer using the age-standardised
figure for age
-groups 35-64 yrs as recommended by the World Health
Organisation2 to avoid the vagaries of diagnosis in the very old. Even so, the
incidence of histologically confirmed tumours in Northern Ireland is as high as or
higher than the registered rates elsewhere in the United Kingdom.
Secondly, the comparability of the incidence derived from the Northern Ireland
Cancer Register with those of other United Kingdom registers can be judged
against a number of indices of reliability which are used in the compilation of
register statistics.2 One such measure is the ratio of cancer deaths in a period to
the number of registrations. From a recent statistical compilation of the Cancer
Research Campaign13 these ratios for colorectal cancer in the United Kingdom
are: England0 72, Wales 0* 73, Scotland 0* 65, and Northern Ireland 0
-73. The
proportion of cases which are registered by death certificate alone may reflect the
extent of under-recording.2 For gastrointestinal tumours in Northern Ireland this
figure is 24%,14and for the regional registers elsewhere in the UK the variation is
between 2% and 18% for colorectal cancer. Another index of reliability used by
the World Health Organisation is the proportion of registrations which have been
histologically confirmed. For the 35-64 yr age groups this varies from 66% to
99% of regional colorectal cancer registrations in the rest of the UK.2 We have
not attempted this form of validation and can only report that during our 3 year
study period the ratio of histological diagnoses to registrations in this age-group
was 521/603 or 0 86to 1.
These observations suggest that the registered incidence of colorectal cancer in
Northern Ireland gives a reasonable reflection of the excess of this disease above
the rates in the rest of the United Kingdom. Although it has been generally
recognised that mortality from colorectal cancer in Northern Ireland is high,
our results indicate that this likely reflects a much higher underlying incidence.
© The Ulster Medical Society, 1990.
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Although the north and south of Ireland share a similar excess, the secular trends
in the countries have not been identical.3 Since it is conceivable that the risk
factors for incidence may not exactly coincide with those for mortality,15 further
work is required to determine the important local determinants of this major
public health problem.
We would like to thank the pathologists and surgeons who gave us access to their material and the
staff ofthe Northern Ireland Cancer Registry Information Technology Team forproviding age-specific
registration details for the study period. Also Mrs Heather Porter for typing the manuscript.
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